HIV-associated cognitive impairment before and after the advent of combination therapy

The objective of this study was to describe the occurrence of HIV dementia and neuropsychological testing abnormalities in a new cohort of HIV-seropositive individuals at high risk for HIV dementia and to compare these results to a cohort before the advent of highly active antiretroviral therapy (HAART). HAART has been associated with improvements in cognitive performance in some HIV-infected patients. However, it is uncertain whether HAART has changed the frequency of specific neurocognitive abnormalities. Baseline data from 272 HIV-seropositive subjects in the Dana cohort recruited from January, 1994, to December, 1995, and 251 HIV-seropositive subjects in the Northeastern AIDS Dementia Consortium (NEAD) cohort recruited from April, 1998, to August, 1999, were compared. Participants in both cohorts received nearly identical assessments. After adjusting for differences in age, education, gender, race, and CD4 count between the two cohorts, there were no differences in the occurrence of HIV dementia or abnormalities either 1 SD or 2 SDs below established norms for any of the neuropsychological tests. Even though HAART has reduced the incidence of HIV dementia, HIV-associated cognitive impairment continues to be a major clinical problem among individuals with advanced infection.

[1]  Andrew J. Saykin,et al.  Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus‐type 1 (HIV‐1) infection , 1991, Neurology.

[2]  O. Selnes,et al.  Normative Data for a Brief Neuropsychological Screening Battery , 1991, Perceptual and motor skills.

[3]  A. Benton,et al.  The visual retention test as a constructional praxis task. , 1962, Confinia neurologica.

[4]  A. Rey.  L'examen psychologique dans les cas d'encéphalopathie traumatique. (Les problems.). , 1941 .

[5]  L. Bérubé,et al.  [Clinical neuropsychology]. , 1982, Nursing Quebec.

[6]  D. McCaffrey,et al.  The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. , 1998, The New England journal of medicine.

[7]  R. Price,et al.  The AIDS dementia complex. , 1988, The Journal of infectious diseases.

[8]  G. Pugliese,et al.  Severe Streptococcus pyogenes Infections, United Kingdom, 2003–2004 , 2008, Emerging infectious diseases.

[9]  S. Katz,et al.  STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION. , 1963, JAMA.

[10]  J. Becker,et al.  Dementia in AIDS patients , 1993, Neurology.

[11]  L. Wilkins.  Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder , 1996, Neurology.

[12]  J. McArthur,et al.  Relationship between human immunodeficiency virus—associated dementia and viral load in cerebrospinal fluid and brain , 1997, Annals of neurology.

[13]  O. Selnes,et al.  Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors. , 2000, Journal of neurovirology.

[14]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[15]  Diane C. Tsai.  Recent Developments in Parkinson's Disease , 1986, The Yale Journal of Biology and Medicine.

[16]  H. Nelson,et al.  Dementia: The Estimation of Premorbid Intelligence Levels Using the New Adult Reading Test , 1978, Cortex.

[17]  H. Brodt,et al.  Changing incidence of AIDS‐defining illnesses in the era of antiretroviral combination therapy , 1997, AIDS.

[18]  L. Chang,et al.  Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia , 1999, Neurology.

[19]  R. Reitan.  Validity of the Trail Making Test as an Indicator of Organic Brain Damage , 1958 .

[20]  J. Becker,et al.  Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy , 1999, Neurology.

[21]  I. Grant,et al.  Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome , 1997, Annals of neurology.

[22]  O. Selnes,et al.  Variable progression of HIV‐associated dementia , 1998, Neurology.

[23]  D. Vlahov,et al.  Normative data for a brief neuropsychologic test battery in a cohort of injecting drug users. , 1995, The International journal of the addictions.

[24]  K. Flowers,et al.  The effect of Parkinson's disease on the ability to maintain a mental set. , 1985, Journal of neurology, neurosurgery, and psychiatry.

[25]  E. Miller,et al.  Computerized and conventional neuropsychological assessment of HIV‐1‐infected homosexual men , 1991, Neurology.

[26]  A. Rey.  Lexamen psychologique : Dans les cas d'encephalopathie traumatique (Les problemes) , 1941 .

[27]  M. Lawton,et al.  Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living , 1969 .

[28]  Hillary C. M. Nelson.  The National Adult Reading Test , 1982 .

[29]  L. Radloff.  The CES-D Scale , 1977 .

[30]  D. Karnofsky,et al.  The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma , 1948 .

[31]  J. Rockstroh,et al.  Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV‐infected patients , 1997, AIDS.

[32]  A. Stewart,et al.  Measuring Functioning and Well-Being: The Medical Outcomes Study Approach , 1992 .